A carregar...
MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells
Tamoxifen is commonly used to treat patients with ESR/ER-positive breast cancer, but its therapeutic benefit is limited by the development of resistance. Recently, alterations in macroautophagy/autophagy function were demonstrated to be a potential mechanism for tamoxifen resistance. Although MTA1 (...
Na minha lista:
| Publicado no: | Autophagy |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6070012/ https://ncbi.nlm.nih.gov/pubmed/29130361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15548627.2017.1388476 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|